Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
회사 코드TEM
회사 이름Tempus AI Inc
상장일Jun 14, 2024
설립일2015
CEOMr. Eric P. Lefkofsky
직원 수2400
유형Ordinary Share
회계 연도 종료Jun 14
주소600 West Chicago Avenue
도시CHICAGO
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호60654
전화18009765448
웹사이트https://www.tempus.com/
회사 코드TEM
상장일Jun 14, 2024
설립일2015
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음